Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2325 (LINC02325) is a human lincRNA gene whose transcript is longer than 200 nucleotides and does not overlap protein-coding regions[1][5][3]. LINC02325 belongs to the long non-coding RNA family, specifically the intergenic subclass[3]. LincRNAs, including LINC02325, are transcribed RNA molecules that function primarily in gene regulatory roles such as chromatin remodeling and regulation of gene expression, often with tissue-specific activity, but usually without direct protein coding function[3][7]. There is currently no well-defined role for LINC02325 itself in disease or therapy, and its detailed biological activity and clinical significance have not been clarified in published research or databases[1][5].
Not applicable. No drugs or therapeutic agents are known to target LINC02325, and thus no mechanism of action is described[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2325 (LINC02325).